This review is a summary of a recent event in Melbourne to discuss evolving best practice related to irARs and cancer immunotherapy patient management.
This meeting and case studies presented and will be the first of a two-part series. Commentary is provided by Associate Professor Andrew Weickhardt, medical oncologist at the Olivia Newton-John Cancer and Wellness Centre in Melbourne.
Please login below to download this issue (PDF)